Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | SLC5A1 | P13866 | 3/20 | 0.51 |
| ▸ | SLC5A2 | P31639 | 3/20 | 0.51 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.48 |
| ▸ | CHRNA5 | P30532 | 1/20 | 0.48 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.48 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.48 |
| ▸ | TYMP | P19971 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23488262 | 0.90 | CHRNB2 (0.51) | TDP1SLC5A1SLC5A2CHRNB2CHRNA5 | |
| SCHEMBL23488668 | 0.90 | CHRNB2 (0.51) | TDP1SLC5A1SLC5A2CHRNB2CHRNA5 | |
| SCHEMBL23488128 | 0.90 | CHRNB2 (0.51) | TDP1SLC5A1SLC5A2CHRNB2CHRNA5 | |
| SCHEMBL23488460 | 0.86 | CHRNB2 (0.49) | TDP1SLC5A1SLC5A2CHRNB2CHRNA5 | |
| SCHEMBL23488173 | 0.83 | CHRNB2 (0.53) | TDP1CHRNB2CHRNA5CHRNA7CHRNA4 | |
| SCHEMBL29220898 | 0.83 | TDP1 (0.58) | TDP1SLC5A1SLC5A2NPC1RAB9A | |
| SCHEMBL23488604 | 0.83 | CHRNB2 (0.53) | TDP1CHRNB2CHRNA5CHRNA7CHRNA4 | |
| SCHEMBL22490902 | 0.83 | CHRNB2 (0.52) | TDP1CHRNB2CHRNA5CHRNA7CHRNA4 | |
| SCHEMBL23488265 | 0.83 | MAOB (0.48) | TDP1SLC5A1SLC5A2CHRNB2CHRNA5 | |
| SCHEMBL23488297 | 0.82 | TDP1 (0.48) | TDP1SLC5A1SLC5A2TYMPMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210170033-A1 | NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | SANOFI (FR) | 2021-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210170033-A1 | NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | GPR119, SLC2A8, SLC2A4 | TDP1 4093/4885SLC5A1 9/4885SLC5A2 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.